IL13 and lung carcinoma: The cytokines produced by “Type 2” immune cells (including ILC2s), IL-5, IL-13 and IL-4, were increased in both PLs and mPEs from lung cancer patients as compared to HD PLs (Supplementary Fig. 2A).